Femipristal Tablet contains Ulipristal acetate 5mg, a selective progesterone receptor modulator used primarily as an emergency contraceptive to prevent unintended pregnancy after unprotected intercourse or contraceptive failure. It works by inhibiting or delaying ovulation, thereby reducing the likelihood of fertilization. Femipristal is effective when taken within 120 hours (5 days) after unprotected sex, offering a wider window of use compared to other emergency contraceptives. The tablet should be taken orally as a single dose, with or without food. It is important to use Femipristal as soon as possible after unprotected intercourse for maximum efficacy. This medication is not intended for regular contraceptive use and does not protect against sexually transmitted infections. Common side effects may include headache, nausea, abdominal pain, and menstrual irregularities, which are generally mild and transient. Femipristal is contraindicated in women with known hypersensitivity to Ulipristal acetate or any of the tablet’s components. It should be used cautiously in patients with liver impairment. Femipristal Tablet is a safe and effective option for emergency contraception when used according to guidelines, providing women with a reliable method to prevent unintended pregnancy after contraceptive failure or unprotected sex.